MK-0616 Overview
Upcoming Projects (MK-0616)
-
Don’t see a project related to the keyword you care about? Create your own!
Executed Projects (MK-0616)
-
A third look: Digging in to the Phase 2b data presented at the AAC Conference for Merck's oral PCSK9 inhibitor, MK-0616, in patients with hypercholesterolemia
Ticker: MRK
Executed On: Mar 14, 2023 at 07:00 PM EDT -
A second look: Digging in to the Phase 2b data presented at the AAC Conference for Merck's oral PCSK9 inhibitor, MK-0616, in patients with hypercholesterolemia
Ticker: MRK
Executed On: Mar 14, 2023 at 06:00 PM EDT -
Digging in to the Phase 2b data presented at the AAC Conference for Merck's oral PCSK9 inhibitor, MK-0616, in patients with hypercholesterolemia
Ticker: MRK
Executed On: Mar 13, 2023 at 04:00 PM EDT
Upcoming & Overdue Catalysts (MK-0616)
-
Don’t see a catalyst related to the keyword you care about? Create your own!
Strategic Initiatives (MK-0616)
-
Don’t see a strategic initiative related to the keyword you care about? Create your own!
